Senators lay into Sanofi for Zika vaccine deal, call for public hearing
Fierce Pharma ------ Sanofi’s commitment to limit price hikes hasn’t won over six U.S. senators who are railing on the drugmaker for a Zika dustup that’s gained considerable attention since vaccine licensing plans were announced late last year. The lawmakers—Sens. Dick Durbin, D-Ill., Sherrod Brown, D-Ohio, Bernie Sanders, I-Vt., Richard Blumenthal, D-Conn., Ed Markey, D-Mass., and Angus King, I-Maine—sent letters to top officials at the U.S. Army and Sanofi, urging pricing assurances should the vaccine candidate make it to market. The Zika virus has subsided since its initial explosive spread around the globe, but the senators note that 40,000 people in U.S. states and territories contracted the disease. To learn more click on the picture below to read the article.